CTX Statistics

Total Valuation

Captor Therapeutics Spolka Akcyjna has a market cap or net worth of PLN 356.24 million. The enterprise value is 306.07 million.

Market Cap	356.24M
Enterprise Value	306.07M

Important Dates

The last earnings date was Thursday, September 19, 2024.

Earnings Date	Sep 19, 2024
Ex-Dividend Date	n/a

Share Statistics

Captor Therapeutics Spolka Akcyjna has 4.66 million shares outstanding. The number of shares has increased by 16.41% in one year.

Shares Outstanding	4.66M
Shares Change (YoY)	+16.41%
Shares Change (QoQ)	+0.66%
Owned by Insiders (%)	36.74%
Owned by Institutions (%)	22.91%
Float	2.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.99
PB Ratio	7.03
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.56
EV / Sales	16.42
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.63

Financial Position

The company has a current ratio of 2.82, with a Debt / Equity ratio of 12.53.

Current Ratio	2.82
Quick Ratio	2.82
Debt / Equity	12.53
Debt / EBITDA	n/a
Debt / FCF	-0.16
Interest Coverage	-170.30

Financial Efficiency

Return on equity (ROE) is -87.91% and return on invested capital (ROIC) is -50.62%.

Return on Equity (ROE)	-87.91%
Return on Assets (ROA)	-38.23%
Return on Capital (ROIC)	-50.62%
Revenue Per Employee	177,524
Profits Per Employee	-444,619
Employee Count	105
Asset Turnover	0.24
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.79% in the last 52 weeks. The beta is 0.60, so Captor Therapeutics Spolka Akcyjna's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-31.79%
50-Day Moving Average	78.34
200-Day Moving Average	82.32
Relative Strength Index (RSI)	48.72
Average Volume (20 Days)	2,438

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Captor Therapeutics Spolka Akcyjna had revenue of PLN 18.64 million and -46.69 million in losses. Loss per share was -9.57.

Revenue	18.64M
Gross Profit	9.69M
Operating Income	-47.68M
Pretax Income	-46.69M
Net Income	-46.69M
EBITDA	-42.87M
EBIT	-47.68M
Loss Per Share	-9.57

Full Income Statement

Balance Sheet

The company has 56.52 million in cash and 6.35 million in debt, giving a net cash position of 50.17 million or 10.76 per share.

Cash & Cash Equivalents	56.52M
Total Debt	6.35M
Net Cash	50.17M
Net Cash Per Share	10.76
Equity (Book Value)	50.68M
Book Value Per Share	10.87
Working Capital	43.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -38.13 million and capital expenditures -2.00 million, giving a free cash flow of -40.13 million.

Operating Cash Flow	-38.13M
Capital Expenditures	-2.00M
Free Cash Flow	-40.13M
FCF Per Share	-8.61

Full Cash Flow Statement

Margins

Gross margin is 51.97%, with operating and profit margins of -255.81% and -250.46%.

Gross Margin	51.97%
Operating Margin	-255.81%
Pretax Margin	-250.46%
Profit Margin	-250.46%
EBITDA Margin	-229.99%
EBIT Margin	-255.81%
FCF Margin	-215.28%

Dividends & Yields

Captor Therapeutics Spolka Akcyjna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.41%
Shareholder Yield	-16.41%
Earnings Yield	-12.53%
FCF Yield	-11.26%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Captor Therapeutics Spolka Akcyjna has an Altman Z-Score of 5.42.

Altman Z-Score	5.42
Piotroski F-Score	n/a